AstraZeneca sells its med tech arm to Dentsply for $1.8 billion in cash | Deals Roundup

AstraZeneca
Dentsply

AstraZeneca plc (NYSE:AZN) announced that it signed a definitive agreement to sell its medical device arm, Astra Tech, to dental device maker Dentsply International Inc. (NSDQ:XRAY) for $1.8 billion in cash.

The merger will put Dentsply in the top three for dental implant market share, according to a company release.

Astra Tech, headquartered in Mölndal, Sweden, has two main device divisions: one in dental implants and one in urology and surgery. The company recorded worldwide revenue of $545 million in 2010.

AstraZeneca announced that it would unload its devices unit in April and set a starting bid at $2.13 billion. Straumann Holding AG (SWF:STMN) and Nobel Biocare Holding AG (VTX:NOBN) dropped out early in June.

York, Pa.-based Dentsply expects the deal to add between 12 and 17 cents per share to its profit in the full first year after the deal closes, according to the release.

Dentsply’s stock closed at $38.32 after the announcement yesterday, a 1.9 percent increase over the previous day’s close, but was back down to $37.80 at the end of the day today.

The deal is expected to close by the end of the year, according to SEC filings.

Here’s a roundup of companies announcing mergers, acquisitions and divestitures.

  • Smith & Nephew acquires Tenet Medical
    Orthopedic device giant Smith & Nephew (NYSE:SNN) announced today that it acquired privately held Tenet Medical for an undisclosed amount. Tenet develops patient positioning systems for surgeons and medical facilities. The news comes on the heels of a $85 million win for SNN in a patent dispute against competitor Arthrex Inc.
    Read more
  • Altor buys Orchid Orthopedic
    Altor Fund III announced that it signed an agreement to acquire Orchid Orthopedic Solutions from Churchill Equity for an undisclosed amount. Orchid supplies design and manufacturing services for orthopedic and dental implants and instruments.
    Read more
  • District Court of Nazareth okays Essilor and Shamir merger
    Israel-based Shamir Optical Industry Ltd. (NSDQ:SHMR) won final approval from the District Court of Nazareth for Essilor Corp. to acquire 50 percent of Shamir, pursuant to approval by company shareholders.
    Read more

  • Luminex to acquire EraGen Biosciences for $34 million
    Luminex Corp. (NSDQ:LMNX) announced plans to acquire EraGen Biosciences by purchasing all outstanding shares of EraGen for about $34 million in cash. The agreement includes a $1.5 million consolation prize for Luminex if EraGen goes with another offer, according to SEC filings. The companies expect the deal to close in the next few weeks.
    Read more

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply